Interesting Research Report on the Future of Cancer Therapeutics and Supportive Care Drugs Market 2017-2023

Cancer Therapeutics and Supportive Care Drugs Market report provides the latest market data along with industry future trends, which keeps tracking of users driving revenue growth rate of Cancer Therapeutics and Supportive Care Drugs Market by type (cancer therapeutics, supportive care drugs), by distribution channel (hospital, retail) market status and outlook of global and major regions, from manufacturers, and end industries. As this report is expected to help key players among the Cancer Therapeutics and Supportive Care Drugs Market it includes the five years Industry analysis and the 6 years annual forecast from 2017 to 2023. Some of the prominent participants in the Global Cancer Therapeutics and Supportive Care Drugs Market are include Abbott Laboratories, AstraZeneca plc, AstellasPharma Inc.,Bristol-Myers Squibb, Johnson & Johnson, Eli Lilly,Novartis,Pfizer Inc, According to the report the Global Cancer Therapeutics and Supportive Care Drugs Market is projected to grow at a CAGR of 9.7% in terms of value over the period of 2017-2023.

Changing Lifestyle Habits of Populations, Increased Patient’s Healthcare Awareness, and Increasing Demand for Non-Invasive Therapies Are Further Expected to Propel the Market Growth in the Coming Years

New treatment options have become available in the past five years, and the surge of innovation is expected to continue due to a robust pipeline of drugs in clinical development by a large and diverse group of pharmaceutical companies. Innovations in the development of new drugs and therapies, large number of new drugs entering into the market with FDA approval, increasing prevalence of cancerous patients, availability of new treatment options in the market and rise in base of aging population are the key driving factors for the growth of this market. In addition, changing lifestyle habits of populations, increased patient’s healthcare awareness, and increasing demand for non-invasive therapies are further expected to propel the market growth in the coming years. Along with these driving factors, the market for cancer therapeutics is facing some challenges such as time consuming regulatory compliance and high cost of cancer drugs. However, the market for cancer therapeutics and supportive care drugs is likely to rise in the future due to the large number of ongoing innovations for the treatment of cancer.

North America is the Leading Contributor to the Market

Geographically, North America is the leading contributor to the market and is expected to retain its position during the forecast period due to high awareness, presence of large base of cancer patients, rise in investments, and various initiatives by government in the healthcare sector. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, technological advancements, significant investments and growing awareness among the population about the treatment options available in the market.

Major Key Player in this Report

The companies covered in the report includeAbbott Laboratories,AstraZeneca plc,AstellasPharma Inc.,Bristol-Myers Squibb,Johnson & Johnson,Eli Lilly,Novartis,Pfizer Inc.,

Table of Contents:-

1. Scope of the Report

1.1 Report Description

1.2 Research Methodology

1.3 List of Abbreviations

1.4 Market Segmentation

2. Executive summary

3. Oncology overview

3.1 Prevalence by cancer type

3.2 New active substance launches by indication, 2011 – 2015

3.3 Oncology drugs approved in 2016

3.4 Drugs in late-phase development for various cancers

4. Qualitative Analysis

4.1 Market overview

4.1.1 Drivers

4.1.2 Restraints

4.2 Porters five forces analysis

4.3 Competitive matrix of the key companies

4.4 Market share analysis

5. Global Cancer Therapeutics and Supportive Care Drugs Market, by Type, 2017 – 2023

5.1 Cancer Therapeutics

5.2 Supportive Care Drugs

6. Global Cancer Therapeutics and Supportive Care Drugs Market, by Distribution Channel, 2017 – 2023

6.1 Hospital

6.2 Retail

7. Global Cancer Therapeutics and Supportive Care Drugs Market, by Geography, 2017 – 2023

7.1 North America

7.2 Europe

7.2.1 Germany

7.2.2 France

7.2.3 Italy

7.2.4 UK

7.2.5 Spain

7.2.6 Others

7.3 APAC

7.3.1 China

7.3.2 India

7.3.3 Japan

7.3.4 Others

7.4 Rest of the World

8 Company profiles

8.1 Abbott Laboratories

8.2 AstraZeneca plc

8.3 Astellas Pharma Inc.

8.4 Bristol-Myers Squibb

8.5 Johnson & Johnson

8.6 Pfizer Inc.

8.7 Novartis

8.8 Eli Lilly

8.9 Sanofi

8.10 AbbVie, Inc.

8.11 Teva Pharmaceuticals

8.12 Takeda Pharmaceuticals

Click the Below Full Report Link: – https://www.infiniumglobalresearch.com/healthcare_medical_devices/cancer_therapeutics_supportive_care_drugs_market

Reset Password